Literature DB >> 8387401

Suramin: an anticancer drug with unique biological effects.

A K Larsen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8387401     DOI： 10.1007/bf00685609

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  34 in total

1.  Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies.

Authors:  L T Williams; P M Tremble; M F Lavin; M E Sunday
Journal:  J Biol Chem       Date:  1984-04-25       Impact factor: 5.157

2.  Suramin: a potent inhibitor of the reverse transcriptase of RNA tumor viruses.

Authors:  E De Clercq
Journal:  Cancer Lett       Date:  1979-11       Impact factor: 8.679

3.  Effects of suramin, an anti-human immunodeficiency virus reverse transcriptase agent, on protein kinase C. Differential activation and inhibition of protein kinase C isozymes.

Authors:  C W Mahoney; A Azzi; K P Huang
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

4.  Suramin, an anti-cancer drug, inhibits protein kinase C and induces differentiation in neuroblastoma cell clone NB2A.

Authors:  C E Hensey; D Boscoboinik; A Azzi
Journal:  FEBS Lett       Date:  1989-11-20       Impact factor: 4.124

5.  Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.

Authors:  R J Coffey; E B Leof; G D Shipley; H L Moses
Journal:  J Cell Physiol       Date:  1987-07       Impact factor: 6.384

6.  Inhibition of vacuolar H+-ATPases by fusidic acid and suramin.

Authors:  Y Moriyama; N Nelson
Journal:  FEBS Lett       Date:  1988-07-18       Impact factor: 4.124

7.  Experimental animal model for mucopolysaccharidosis: suramin-induced glycosaminoglycan and sphingolipid accumulation in the rat.

Authors:  G Constantopoulos; S Rees; B G Cragg; J A Barranger; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

8.  Suramin inhibits cell growth and glycolytic activity and triggers differentiation of human colic adenocarcinoma cell clone HT29-D4.

Authors:  J Fantini; J B Rognoni; M Roccabianca; G Pommier; J Marvaldi
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

9.  Suramin binds to platelet-derived growth factor and inhibits its biological activity.

Authors:  M Hosang
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

10.  Intralysosomal accumulation of polyanions. II. Polyanion internalization and its influence on lysosomal pH and membrane fluidity.

Authors:  M C Kielian; Z A Cohn
Journal:  J Cell Biol       Date:  1982-06       Impact factor: 10.539
View more
  8 in total

Review 1.  The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.

Authors:  Katrien Vermeulen; Dirk R Van Bockstaele; Zwi N Berneman
Journal:  Cell Prolif       Date:  2003-06       Impact factor: 6.831

Review 2.  Angiogenesis: possibilities for therapeutic interventions.

Authors:  W Wynendaele; A T van Oosterom; A Pawinski; E A de Bruijn; R A Maes
Journal:  Pharm World Sci       Date:  1998-12

3.  Suramin treatment of human glioma xenografts; effects on tumor vasculature and oxygenation status.

Authors:  H J Bernsen; P F Rijken; J P Peters; J H Bakker; R H Boerman; P Wesseling; A J van der Kogel
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

Review 4.  Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

Authors:  John L Hamilton; Masashi Nagao; Brett R Levine; Di Chen; Bjorn R Olsen; Hee-Jeong Im
Journal:  J Bone Miner Res       Date:  2016-04-08       Impact factor: 6.741

5.  Suramin inhibits cell proliferation in ovarian and cervical cancer by downregulating heparanase expression.

Authors:  HuaPing Li; HuaLi Li; HongJie Qu; MingZhu Zhao; Bo Yuan; MingHua Cao; JinQuan Cui
Journal:  Cancer Cell Int       Date:  2015-05-13       Impact factor: 5.722

6.  Structural Basis of Inhibition of the Pioneer Transcription Factor NF-Y by Suramin.

Authors:  Valentina Nardone; Antonio Chaves-Sanjuan; Michela Lapi; Cristina Airoldi; Andrea Saponaro; Sebastiano Pasqualato; Diletta Dolfini; Carlo Camilloni; Andrea Bernardini; Nerina Gnesutta; Roberto Mantovani; Marco Nardini
Journal:  Cells       Date:  2020-10-29       Impact factor: 6.600

Review 7.  A Second WNT for Old Drugs: Drug Repositioning against WNT-Dependent Cancers.

Authors:  Kamal Ahmed; Holly V Shaw; Alexey Koval; Vladimir L Katanaev
Journal:  Cancers (Basel)       Date:  2016-07-14       Impact factor: 6.639

8.  Direct High-Throughput Screening Assay for mRNA Cap Guanine-N7 Methyltransferase Activity.

Authors:  Renata Kasprzyk; Mateusz Fido; Adam Mamot; Przemyslaw Wanat; Miroslaw Smietanski; Michal Kopcial; Victoria H Cowling; Joanna Kowalska; Jacek Jemielity
Journal:  Chemistry       Date:  2020-08-10       Impact factor: 5.020
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.